OGI

OrganiGram Hldg
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.193
-0.027
-2.19%
Opening 15:30 10/28 EDT
OPEN
1.210
PREV CLOSE
1.220
HIGH
1.250
LOW
1.180
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
4.010
52 WEEK LOW
1.010
MARKET CAP
232.11M
P/E (TTM)
-2.3023
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Organigram confirms additional $2.5M investment in Hyasynth Biologicals
Organigram ([[OGI]] +0.8%) funds an additional $2.5M investment in Hyasynth Biologicals, a private biotechnology company.Today’s announcement represents the second of total three tranches outlined in the agreement and brings total
Seekingalpha · 5d ago
Organigram Confirms Added $2.5M Investment In Hyasynth Biologicals
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis,
Benzinga · 5d ago
Organigram Confirms Additional $2.5 Million Investment in Hyasynth Biologicals Inc. as Biosynthesis Pioneer Completes First Milestone Linked to First Sale of Commercial Product and Announces Executive Changes
As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has funded an additional $2.5 million investment in Hyasynth Biologicals Inc. ("Hyasynth"), a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis. The announcement comes as Hyasynth makes the first sale of CBDa1 produced and extracted from yeast.
Business Wire · 5d ago
A Look At How MSOs Navigate A Ballooning Cannabis Market, Set To Reach $80B By 2030
Federal law still regards cannabis as a Schedule I controlled substance, and neither major-party presidential candidate — U.S. President Donald Trump and former Vice President Joe Biden — supports legalizing it.
Benzinga · 10/12 13:48
Cannabis stocks get a broad boost after veep-candidate Kamala Harris said Biden administration would decriminalize marijuana
Shares of cannabis companies enjoyed a broad rally Thursday, amid growing hopes of federal decriminalization following comments from vice-presidential...
marketwatch.com · 10/08 15:27
Why Aphria, Curaleaf, and Several Other Cannabis Stocks Are Flying Higher Today
MotleyFool.com · 10/08 13:54
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
Nike, OrganiGram, Thermo Fisher, Danaher Corp and Agilent Tech highlighted as Zacks Bull and Bear of the Day
Zacks · 09/30 14:41
Bear of the Day: OrganiGram Holdings (OGI)
Bear of the Day: OrganiGram Holdings (OGI)
Zacks · 09/30 11:10
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OGI. Analyze the recent business situations of OrganiGram Hldg through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OGI stock price target is 3.589 with a high estimate of 3.589 and a low estimate of 3.589.
EPS
Institutional Holdings
Institutions: 145
Institutional Holdings: 20.47M
% Owned: 10.52%
Shares Outstanding: 194.51M
TypeInstitutionsShares
Increased
24
3.15M
New
39
-2.42M
Decreased
19
540.61K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-2.25%
Pharmaceuticals & Medical Research
-2.11%
Key Executives
Chairman/Independent Director
Peter Amirault
Chief Executive Officer/Director
Greg Engel
Chief Executive Officer/Director
Gregory Engel
Chief Financial Officer
Derrick West
Senior Vice President/Director of Sales
Timothy Emberg
Senior Vice President/Secretary
Helen Martin
Senior Vice President
Jeffrey Purcell
Vice President - Operations
Matthew Rogers
Vice President/Director of Sales
Tim Emberg
Vice President/Director of Investor Relations
Amy Schwalm
Vice President/Director of Marketing
Julie Chamberlain
Vice President
Cameron Bishop
Other
Paolo De Luca
Independent Director
Dexter John
Independent Director
Sherry Porter
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About OGI
OrganiGram Holdings Inc, formerly Inform Exploration Corp, is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc is a licensed medical marijuana producer of dried cannabis and cannabis oil. The Company is permitted to possess, produce, sell, provide, ship, deliver, transport and destroy cannabis, cannabis plants (including plants and seeds) and cannabis oil, in conformity with cannabis Act. The Company is also authorized for wholesale shipping of cannabis plant cuttings, dried flower, blends, pre-rolls and cannabis oil to approved retailers and wholesalers for adult-use recreational cannabis under individual provincial and territorial regulations as per Cannabis Act. The Company distributes its products mainly through the Company’s online store or by phone.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of OrganiGram Holdings Inc stock information, including NASDAQ:OGI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OGI stock methods without spending real money on the virtual paper trading platform.